Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival – Surviving Mesothelioma
Surviving MesotheliomaSecond-Line Immunotherapy Treatment Fails to Improve Mesothelioma SurvivalSurviving MesotheliomaA large international clinical trial of the immunotherapy drug tremelimumab as a second- or third-line treatment option for malignant … Continue reading
